nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—NR0B1—Dexamethasone—multiple sclerosis	0.186	0.264	CbGbCtD
Vincristine—ABCC10—Methotrexate—multiple sclerosis	0.055	0.0779	CbGbCtD
Vincristine—ABCC1—Mitoxantrone—multiple sclerosis	0.051	0.0722	CbGbCtD
Vincristine—ABCG2—Cladribine—multiple sclerosis	0.0468	0.0663	CbGbCtD
Vincristine—ABCB11—Dexamethasone—multiple sclerosis	0.0372	0.0527	CbGbCtD
Vincristine—ABCC3—Methotrexate—multiple sclerosis	0.0346	0.049	CbGbCtD
Vincristine—ABCG2—Mitoxantrone—multiple sclerosis	0.0341	0.0483	CbGbCtD
Vincristine—ABCC1—Methotrexate—multiple sclerosis	0.0212	0.0301	CbGbCtD
Vincristine—ABCC2—Dexamethasone—multiple sclerosis	0.0196	0.0277	CbGbCtD
Vincristine—ABCG2—Dexamethasone—multiple sclerosis	0.0177	0.0251	CbGbCtD
Vincristine—ABCB1—Methylprednisolone—multiple sclerosis	0.0169	0.0239	CbGbCtD
Vincristine—ABCC2—Methotrexate—multiple sclerosis	0.0157	0.0223	CbGbCtD
Vincristine—CYP3A4—Fingolimod—multiple sclerosis	0.0157	0.0222	CbGbCtD
Vincristine—ABCG2—Methotrexate—multiple sclerosis	0.0142	0.0201	CbGbCtD
Vincristine—CYP3A7—Dexamethasone—multiple sclerosis	0.0131	0.0185	CbGbCtD
Vincristine—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0131	0.0185	CbGbCtD
Vincristine—ABCB1—Mitoxantrone—multiple sclerosis	0.0123	0.0174	CbGbCtD
Vincristine—ABCB1—Betamethasone—multiple sclerosis	0.011	0.0155	CbGbCtD
Vincristine—ABCB1—Prednisolone—multiple sclerosis	0.0108	0.0153	CbGbCtD
Vincristine—ABCB1—Prednisone—multiple sclerosis	0.0102	0.0145	CbGbCtD
Vincristine—CYP3A4—Methylprednisolone—multiple sclerosis	0.0101	0.0143	CbGbCtD
Vincristine—CYP3A5—Dexamethasone—multiple sclerosis	0.0098	0.0139	CbGbCtD
Vincristine—CYP3A4—Triamcinolone—multiple sclerosis	0.00766	0.0108	CbGbCtD
Vincristine—CYP3A4—Mitoxantrone—multiple sclerosis	0.00737	0.0104	CbGbCtD
Vincristine—CYP3A4—Betamethasone—multiple sclerosis	0.00657	0.00931	CbGbCtD
Vincristine—CYP3A4—Prednisolone—multiple sclerosis	0.00648	0.00918	CbGbCtD
Vincristine—ABCB1—Dexamethasone—multiple sclerosis	0.00638	0.00904	CbGbCtD
Vincristine—CYP3A4—Prednisone—multiple sclerosis	0.00612	0.00867	CbGbCtD
Vincristine—ABCB1—Methotrexate—multiple sclerosis	0.00512	0.00726	CbGbCtD
Vincristine—TUBA4A—pineal body—multiple sclerosis	0.00506	0.0687	CbGeAlD
Vincristine—CYP3A4—Dexamethasone—multiple sclerosis	0.00382	0.00541	CbGbCtD
Vincristine—TUBB8—nervous system—multiple sclerosis	0.00159	0.0217	CbGeAlD
Vincristine—TUBA4A—brainstem—multiple sclerosis	0.00158	0.0214	CbGeAlD
Vincristine—TUBB8—central nervous system—multiple sclerosis	0.00154	0.0209	CbGeAlD
Vincristine—TUBA4A—retina—multiple sclerosis	0.00152	0.0207	CbGeAlD
Vincristine—TUBB—Azacitidine—Cladribine—multiple sclerosis	0.00145	0.708	CbGdCrCtD
Vincristine—RALBP1—retina—multiple sclerosis	0.00143	0.0195	CbGeAlD
Vincristine—TUBB4A—brainstem—multiple sclerosis	0.00126	0.0172	CbGeAlD
Vincristine—TUBB4A—retina—multiple sclerosis	0.00122	0.0166	CbGeAlD
Vincristine—TUBB8—brain—multiple sclerosis	0.00122	0.0166	CbGeAlD
Vincristine—TUBB2B—retina—multiple sclerosis	0.00118	0.016	CbGeAlD
Vincristine—NR0B1—brain—multiple sclerosis	0.00113	0.0154	CbGeAlD
Vincristine—TUBA4A—medulla oblongata—multiple sclerosis	0.0011	0.0149	CbGeAlD
Vincristine—TUBB3—nervous system—multiple sclerosis	0.00109	0.0148	CbGeAlD
Vincristine—TUBB1—nervous system—multiple sclerosis	0.00106	0.0145	CbGeAlD
Vincristine—TUBB3—central nervous system—multiple sclerosis	0.00105	0.0142	CbGeAlD
Vincristine—RALBP1—medulla oblongata—multiple sclerosis	0.00104	0.0141	CbGeAlD
Vincristine—TUBB1—central nervous system—multiple sclerosis	0.00102	0.0139	CbGeAlD
Vincristine—TUBB3—cerebellum—multiple sclerosis	0.00102	0.0139	CbGeAlD
Vincristine—TUBA4A—midbrain—multiple sclerosis	0.00101	0.0137	CbGeAlD
Vincristine—TUBA4A—spinal cord—multiple sclerosis	0.000981	0.0133	CbGeAlD
Vincristine—TUBB4B—retina—multiple sclerosis	0.000951	0.0129	CbGeAlD
Vincristine—RALBP1—midbrain—multiple sclerosis	0.000947	0.0129	CbGeAlD
Vincristine—RALBP1—spinal cord—multiple sclerosis	0.000924	0.0126	CbGeAlD
Vincristine—TUBB4A—medulla oblongata—multiple sclerosis	0.000881	0.012	CbGeAlD
Vincristine—TUBB2B—medulla oblongata—multiple sclerosis	0.000852	0.0116	CbGeAlD
Vincristine—TUBB3—brain—multiple sclerosis	0.000832	0.0113	CbGeAlD
Vincristine—TUBA4A—nervous system—multiple sclerosis	0.000826	0.0112	CbGeAlD
Vincristine—TUBB1—brain—multiple sclerosis	0.000813	0.011	CbGeAlD
Vincristine—TUBB—medulla oblongata—multiple sclerosis	0.000806	0.0109	CbGeAlD
Vincristine—TUBB4A—midbrain—multiple sclerosis	0.000805	0.0109	CbGeAlD
Vincristine—TUBB2A—medulla oblongata—multiple sclerosis	0.000802	0.0109	CbGeAlD
Vincristine—TUBA4A—central nervous system—multiple sclerosis	0.000795	0.0108	CbGeAlD
Vincristine—TUBB6—medulla oblongata—multiple sclerosis	0.000791	0.0107	CbGeAlD
Vincristine—TUBB4A—spinal cord—multiple sclerosis	0.000786	0.0107	CbGeAlD
Vincristine—RALBP1—nervous system—multiple sclerosis	0.000779	0.0106	CbGeAlD
Vincristine—TUBB2B—midbrain—multiple sclerosis	0.000778	0.0106	CbGeAlD
Vincristine—TUBA4A—cerebellum—multiple sclerosis	0.000777	0.0106	CbGeAlD
Vincristine—TUBB2B—spinal cord—multiple sclerosis	0.00076	0.0103	CbGeAlD
Vincristine—RALBP1—central nervous system—multiple sclerosis	0.00075	0.0102	CbGeAlD
Vincristine—TUBB—midbrain—multiple sclerosis	0.000737	0.01	CbGeAlD
Vincristine—RALBP1—cerebellum—multiple sclerosis	0.000733	0.00995	CbGeAlD
Vincristine—TUBB2A—midbrain—multiple sclerosis	0.000733	0.00995	CbGeAlD
Vincristine—TUBB6—midbrain—multiple sclerosis	0.000723	0.00982	CbGeAlD
Vincristine—TUBB—spinal cord—multiple sclerosis	0.000719	0.00976	CbGeAlD
Vincristine—TUBB2A—spinal cord—multiple sclerosis	0.000715	0.00971	CbGeAlD
Vincristine—TUBB6—spinal cord—multiple sclerosis	0.000705	0.00958	CbGeAlD
Vincristine—ABCC10—medulla oblongata—multiple sclerosis	0.000692	0.0094	CbGeAlD
Vincristine—TUBB4B—medulla oblongata—multiple sclerosis	0.000687	0.00934	CbGeAlD
Vincristine—TUBB4A—nervous system—multiple sclerosis	0.000662	0.00899	CbGeAlD
Vincristine—TUBB2B—nervous system—multiple sclerosis	0.00064	0.00869	CbGeAlD
Vincristine—TUBB4A—central nervous system—multiple sclerosis	0.000637	0.00866	CbGeAlD
Vincristine—ABCC10—midbrain—multiple sclerosis	0.000633	0.0086	CbGeAlD
Vincristine—TUBA4A—brain—multiple sclerosis	0.000632	0.00858	CbGeAlD
Vincristine—TUBB4B—midbrain—multiple sclerosis	0.000628	0.00853	CbGeAlD
Vincristine—TUBB4A—cerebellum—multiple sclerosis	0.000623	0.00846	CbGeAlD
Vincristine—ABCC10—spinal cord—multiple sclerosis	0.000617	0.00839	CbGeAlD
Vincristine—TUBB2B—central nervous system—multiple sclerosis	0.000616	0.00837	CbGeAlD
Vincristine—TUBB4B—spinal cord—multiple sclerosis	0.000613	0.00833	CbGeAlD
Vincristine—TUBB2A—nervous system—multiple sclerosis	0.000602	0.00818	CbGeAlD
Vincristine—TUBB2B—cerebellum—multiple sclerosis	0.000602	0.00818	CbGeAlD
Vincristine—TUBB6—Azacitidine—Cladribine—multiple sclerosis	0.0006	0.292	CbGdCrCtD
Vincristine—RALBP1—brain—multiple sclerosis	0.000595	0.00808	CbGeAlD
Vincristine—TUBB6—nervous system—multiple sclerosis	0.000594	0.00807	CbGeAlD
Vincristine—TUBB2A—central nervous system—multiple sclerosis	0.00058	0.00788	CbGeAlD
Vincristine—TUBB6—central nervous system—multiple sclerosis	0.000572	0.00777	CbGeAlD
Vincristine—TUBB—cerebellum—multiple sclerosis	0.00057	0.00774	CbGeAlD
Vincristine—TUBB2A—cerebellum—multiple sclerosis	0.000567	0.0077	CbGeAlD
Vincristine—TUBB6—cerebellum—multiple sclerosis	0.000559	0.00759	CbGeAlD
Vincristine—ABCC3—nervous system—multiple sclerosis	0.000523	0.0071	CbGeAlD
Vincristine—TUBB4B—nervous system—multiple sclerosis	0.000516	0.00702	CbGeAlD
Vincristine—TUBB4A—brain—multiple sclerosis	0.000506	0.00687	CbGeAlD
Vincristine—ABCC3—central nervous system—multiple sclerosis	0.000503	0.00684	CbGeAlD
Vincristine—TUBB4B—central nervous system—multiple sclerosis	0.000497	0.00675	CbGeAlD
Vincristine—ABCC10—cerebellum—multiple sclerosis	0.00049	0.00665	CbGeAlD
Vincristine—TUBB2B—brain—multiple sclerosis	0.000489	0.00664	CbGeAlD
Vincristine—TUBB4B—cerebellum—multiple sclerosis	0.000486	0.0066	CbGeAlD
Vincristine—TUBB—brain—multiple sclerosis	0.000463	0.00629	CbGeAlD
Vincristine—TUBB2A—brain—multiple sclerosis	0.00046	0.00625	CbGeAlD
Vincristine—TUBB6—brain—multiple sclerosis	0.000454	0.00617	CbGeAlD
Vincristine—SLC22A3—nervous system—multiple sclerosis	0.000445	0.00605	CbGeAlD
Vincristine—SLC22A3—central nervous system—multiple sclerosis	0.000428	0.00582	CbGeAlD
Vincristine—ABCG2—medulla oblongata—multiple sclerosis	0.000405	0.00551	CbGeAlD
Vincristine—ABCC3—brain—multiple sclerosis	0.0004	0.00543	CbGeAlD
Vincristine—ABCC10—brain—multiple sclerosis	0.000398	0.0054	CbGeAlD
Vincristine—TUBB4B—brain—multiple sclerosis	0.000395	0.00536	CbGeAlD
Vincristine—ABCG2—midbrain—multiple sclerosis	0.000371	0.00503	CbGeAlD
Vincristine—ABCG2—spinal cord—multiple sclerosis	0.000362	0.00491	CbGeAlD
Vincristine—ABCC1—cerebellum—multiple sclerosis	0.000346	0.0047	CbGeAlD
Vincristine—SLC22A3—brain—multiple sclerosis	0.00034	0.00462	CbGeAlD
Vincristine—ABCG2—cerebellum—multiple sclerosis	0.000287	0.00389	CbGeAlD
Vincristine—ABCC1—brain—multiple sclerosis	0.000281	0.00382	CbGeAlD
Vincristine—ABCB1—retina—multiple sclerosis	0.000277	0.00376	CbGeAlD
Vincristine—ABCG2—brain—multiple sclerosis	0.000233	0.00316	CbGeAlD
Vincristine—Rash—Cladribine—multiple sclerosis	0.000214	0.00131	CcSEcCtD
Vincristine—Hallucination—Betamethasone—multiple sclerosis	0.000214	0.00131	CcSEcCtD
Vincristine—Hallucination—Dexamethasone—multiple sclerosis	0.000214	0.00131	CcSEcCtD
Vincristine—Dermatitis—Cladribine—multiple sclerosis	0.000214	0.00131	CcSEcCtD
Vincristine—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000213	0.00131	CcSEcCtD
Vincristine—Anorexia—Mitoxantrone—multiple sclerosis	0.000213	0.0013	CcSEcCtD
Vincristine—Ataxia—Methotrexate—multiple sclerosis	0.000213	0.0013	CcSEcCtD
Vincristine—Headache—Cladribine—multiple sclerosis	0.000213	0.0013	CcSEcCtD
Vincristine—CYP3A4—nervous system—multiple sclerosis	0.000212	0.00288	CbGeAlD
Vincristine—Weight decreased—Prednisone—multiple sclerosis	0.000212	0.0013	CcSEcCtD
Vincristine—Hypotension—Mitoxantrone—multiple sclerosis	0.000209	0.00128	CcSEcCtD
Vincristine—Depression—Prednisone—multiple sclerosis	0.000208	0.00128	CcSEcCtD
Vincristine—Mental disorder—Methylprednisolone—multiple sclerosis	0.000207	0.00127	CcSEcCtD
Vincristine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.000206	0.00126	CcSEcCtD
Vincristine—Myocardial infarction—Prednisone—multiple sclerosis	0.000204	0.00125	CcSEcCtD
Vincristine—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000204	0.00125	CcSEcCtD
Vincristine—CYP3A4—central nervous system—multiple sclerosis	0.000204	0.00277	CbGeAlD
Vincristine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000203	0.00125	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000203	0.00125	CcSEcCtD
Vincristine—Nausea—Cladribine—multiple sclerosis	0.000202	0.00124	CcSEcCtD
Vincristine—Vertigo—Prednisolone—multiple sclerosis	0.000202	0.00124	CcSEcCtD
Vincristine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.0002	0.00123	CcSEcCtD
Vincristine—ABCB1—medulla oblongata—multiple sclerosis	0.0002	0.00272	CbGeAlD
Vincristine—Back pain—Triamcinolone—multiple sclerosis	0.0002	0.00122	CcSEcCtD
Vincristine—Angiopathy—Dexamethasone—multiple sclerosis	0.000195	0.0012	CcSEcCtD
Vincristine—Angiopathy—Betamethasone—multiple sclerosis	0.000195	0.0012	CcSEcCtD
Vincristine—Convulsion—Prednisolone—multiple sclerosis	0.000194	0.00119	CcSEcCtD
Vincristine—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000194	0.00119	CcSEcCtD
Vincristine—Hypertension—Prednisolone—multiple sclerosis	0.000194	0.00119	CcSEcCtD
Vincristine—Fatigue—Mitoxantrone—multiple sclerosis	0.000192	0.00118	CcSEcCtD
Vincristine—Pain—Mitoxantrone—multiple sclerosis	0.000191	0.00117	CcSEcCtD
Vincristine—Constipation—Mitoxantrone—multiple sclerosis	0.000191	0.00117	CcSEcCtD
Vincristine—Alopecia—Dexamethasone—multiple sclerosis	0.00019	0.00117	CcSEcCtD
Vincristine—Alopecia—Betamethasone—multiple sclerosis	0.00019	0.00117	CcSEcCtD
Vincristine—Diarrhoea—Azathioprine—multiple sclerosis	0.000189	0.00116	CcSEcCtD
Vincristine—Hallucination—Prednisone—multiple sclerosis	0.000186	0.00114	CcSEcCtD
Vincristine—Pancytopenia—Methotrexate—multiple sclerosis	0.000186	0.00114	CcSEcCtD
Vincristine—Vertigo—Triamcinolone—multiple sclerosis	0.000185	0.00114	CcSEcCtD
Vincristine—Vertigo—Methylprednisolone—multiple sclerosis	0.000185	0.00113	CcSEcCtD
Vincristine—Connective tissue disorder—Prednisone—multiple sclerosis	0.000184	0.00113	CcSEcCtD
Vincristine—Oedema—Prednisolone—multiple sclerosis	0.000183	0.00112	CcSEcCtD
Vincristine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000183	0.00112	CcSEcCtD
Vincristine—Neutropenia—Methotrexate—multiple sclerosis	0.000183	0.00112	CcSEcCtD
Vincristine—Dysuria—Methotrexate—multiple sclerosis	0.000183	0.00112	CcSEcCtD
Vincristine—ABCB1—midbrain—multiple sclerosis	0.000183	0.00248	CbGeAlD
Vincristine—Dizziness—Azathioprine—multiple sclerosis	0.000183	0.00112	CcSEcCtD
Vincristine—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000182	0.00112	CcSEcCtD
Vincristine—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00018	0.0011	CcSEcCtD
Vincristine—Convulsion—Triamcinolone—multiple sclerosis	0.000179	0.0011	CcSEcCtD
Vincristine—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000178	0.00109	CcSEcCtD
Vincristine—Convulsion—Methylprednisolone—multiple sclerosis	0.000178	0.00109	CcSEcCtD
Vincristine—ABCB1—spinal cord—multiple sclerosis	0.000178	0.00242	CbGeAlD
Vincristine—Hypertension—Triamcinolone—multiple sclerosis	0.000178	0.00109	CcSEcCtD
Vincristine—Hypertension—Methylprednisolone—multiple sclerosis	0.000178	0.00109	CcSEcCtD
Vincristine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000177	0.00109	CcSEcCtD
Vincristine—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000176	0.00108	CcSEcCtD
Vincristine—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000176	0.00108	CcSEcCtD
Vincristine—Myalgia—Triamcinolone—multiple sclerosis	0.000176	0.00108	CcSEcCtD
Vincristine—Vomiting—Azathioprine—multiple sclerosis	0.000176	0.00108	CcSEcCtD
Vincristine—Pneumonia—Methotrexate—multiple sclerosis	0.000175	0.00108	CcSEcCtD
Vincristine—Myalgia—Methylprednisolone—multiple sclerosis	0.000175	0.00107	CcSEcCtD
Vincristine—Rash—Azathioprine—multiple sclerosis	0.000174	0.00107	CcSEcCtD
Vincristine—Dermatitis—Azathioprine—multiple sclerosis	0.000174	0.00107	CcSEcCtD
Vincristine—Depression—Methotrexate—multiple sclerosis	0.000174	0.00107	CcSEcCtD
Vincristine—Headache—Azathioprine—multiple sclerosis	0.000173	0.00106	CcSEcCtD
Vincristine—Stomatitis—Methotrexate—multiple sclerosis	0.00017	0.00104	CcSEcCtD
Vincristine—Angiopathy—Prednisone—multiple sclerosis	0.00017	0.00104	CcSEcCtD
Vincristine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000168	0.00103	CcSEcCtD
Vincristine—Oedema—Triamcinolone—multiple sclerosis	0.000168	0.00103	CcSEcCtD
Vincristine—Vertigo—Dexamethasone—multiple sclerosis	0.000168	0.00103	CcSEcCtD
Vincristine—Vertigo—Betamethasone—multiple sclerosis	0.000168	0.00103	CcSEcCtD
Vincristine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000168	0.00103	CcSEcCtD
Vincristine—Infection—Triamcinolone—multiple sclerosis	0.000167	0.00103	CcSEcCtD
Vincristine—Sweating—Methotrexate—multiple sclerosis	0.000167	0.00102	CcSEcCtD
Vincristine—Infection—Methylprednisolone—multiple sclerosis	0.000167	0.00102	CcSEcCtD
Vincristine—Insomnia—Prednisolone—multiple sclerosis	0.000166	0.00102	CcSEcCtD
Vincristine—Alopecia—Prednisone—multiple sclerosis	0.000165	0.00101	CcSEcCtD
Vincristine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000165	0.00101	CcSEcCtD
Vincristine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000164	0.00101	CcSEcCtD
Vincristine—Paraesthesia—Prednisolone—multiple sclerosis	0.000164	0.00101	CcSEcCtD
Vincristine—Mental disorder—Prednisone—multiple sclerosis	0.000164	0.00101	CcSEcCtD
Vincristine—Nausea—Azathioprine—multiple sclerosis	0.000164	0.00101	CcSEcCtD
Vincristine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000163	0.000998	CcSEcCtD
Vincristine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000162	0.000996	CcSEcCtD
Vincristine—Convulsion—Betamethasone—multiple sclerosis	0.000162	0.000994	CcSEcCtD
Vincristine—Convulsion—Dexamethasone—multiple sclerosis	0.000162	0.000994	CcSEcCtD
Vincristine—Hypertension—Dexamethasone—multiple sclerosis	0.000162	0.000991	CcSEcCtD
Vincristine—Hypertension—Betamethasone—multiple sclerosis	0.000162	0.000991	CcSEcCtD
Vincristine—Asthenia—Mitoxantrone—multiple sclerosis	0.00016	0.000982	CcSEcCtD
Vincristine—Myalgia—Dexamethasone—multiple sclerosis	0.000159	0.000977	CcSEcCtD
Vincristine—Myalgia—Betamethasone—multiple sclerosis	0.000159	0.000977	CcSEcCtD
Vincristine—Hypotension—Methylprednisolone—multiple sclerosis	0.000157	0.000962	CcSEcCtD
Vincristine—Pain—Prednisolone—multiple sclerosis	0.000157	0.00096	CcSEcCtD
Vincristine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000155	0.000948	CcSEcCtD
Vincristine—Urethral disorder—Methotrexate—multiple sclerosis	0.000153	0.000941	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000153	0.000941	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000153	0.000938	CcSEcCtD
Vincristine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000153	0.000937	CcSEcCtD
Vincristine—Oedema—Dexamethasone—multiple sclerosis	0.000153	0.000937	CcSEcCtD
Vincristine—Oedema—Betamethasone—multiple sclerosis	0.000153	0.000937	CcSEcCtD
Vincristine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000153	0.000937	CcSEcCtD
Vincristine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000153	0.000936	CcSEcCtD
Vincristine—Insomnia—Triamcinolone—multiple sclerosis	0.000152	0.000934	CcSEcCtD
Vincristine—Insomnia—Methylprednisolone—multiple sclerosis	0.000152	0.000932	CcSEcCtD
Vincristine—Infection—Dexamethasone—multiple sclerosis	0.000152	0.000931	CcSEcCtD
Vincristine—Infection—Betamethasone—multiple sclerosis	0.000152	0.000931	CcSEcCtD
Vincristine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000151	0.000927	CcSEcCtD
Vincristine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000151	0.000925	CcSEcCtD
Vincristine—Anaemia—Prednisone—multiple sclerosis	0.000151	0.000924	CcSEcCtD
Vincristine—ABCB1—nervous system—multiple sclerosis	0.00015	0.00204	CbGeAlD
Vincristine—Nervous system disorder—Betamethasone—multiple sclerosis	0.00015	0.000919	CcSEcCtD
Vincristine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00015	0.000919	CcSEcCtD
Vincristine—Agitation—Prednisone—multiple sclerosis	0.00015	0.000918	CcSEcCtD
Vincristine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.00015	0.000917	CcSEcCtD
Vincristine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.00015	0.000917	CcSEcCtD
Vincristine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000148	0.000905	CcSEcCtD
Vincristine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000148	0.000905	CcSEcCtD
Vincristine—Vertigo—Prednisone—multiple sclerosis	0.000146	0.000898	CcSEcCtD
Vincristine—Anorexia—Dexamethasone—multiple sclerosis	0.000146	0.000893	CcSEcCtD
Vincristine—Anorexia—Betamethasone—multiple sclerosis	0.000146	0.000893	CcSEcCtD
Vincristine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000145	0.000891	CcSEcCtD
Vincristine—Fatigue—Triamcinolone—multiple sclerosis	0.000145	0.00089	CcSEcCtD
Vincristine—Fatigue—Methylprednisolone—multiple sclerosis	0.000145	0.000888	CcSEcCtD
Vincristine—ABCB1—central nervous system—multiple sclerosis	0.000145	0.00196	CbGeAlD
Vincristine—Pain—Triamcinolone—multiple sclerosis	0.000144	0.000883	CcSEcCtD
Vincristine—Hypotension—Betamethasone—multiple sclerosis	0.000143	0.000875	CcSEcCtD
Vincristine—Hypotension—Dexamethasone—multiple sclerosis	0.000143	0.000875	CcSEcCtD
Vincristine—Angiopathy—Methotrexate—multiple sclerosis	0.000142	0.000871	CcSEcCtD
Vincristine—Vomiting—Mitoxantrone—multiple sclerosis	0.000142	0.00087	CcSEcCtD
Vincristine—ABCB1—cerebellum—multiple sclerosis	0.000141	0.00192	CbGeAlD
Vincristine—Convulsion—Prednisone—multiple sclerosis	0.000141	0.000866	CcSEcCtD
Vincristine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000141	0.000865	CcSEcCtD
Vincristine—Hypertension—Prednisone—multiple sclerosis	0.000141	0.000863	CcSEcCtD
Vincristine—Rash—Mitoxantrone—multiple sclerosis	0.000141	0.000863	CcSEcCtD
Vincristine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000141	0.000862	CcSEcCtD
Vincristine—Headache—Mitoxantrone—multiple sclerosis	0.00014	0.000857	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000139	0.000853	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000139	0.000853	CcSEcCtD
Vincristine—Myalgia—Prednisone—multiple sclerosis	0.000139	0.000851	CcSEcCtD
Vincristine—Alopecia—Methotrexate—multiple sclerosis	0.000138	0.000848	CcSEcCtD
Vincristine—Insomnia—Dexamethasone—multiple sclerosis	0.000138	0.000847	CcSEcCtD
Vincristine—Insomnia—Betamethasone—multiple sclerosis	0.000138	0.000847	CcSEcCtD
Vincristine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000137	0.000842	CcSEcCtD
Vincristine—Paraesthesia—Betamethasone—multiple sclerosis	0.000137	0.000841	CcSEcCtD
Vincristine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000137	0.000841	CcSEcCtD
Vincristine—Mental disorder—Methotrexate—multiple sclerosis	0.000137	0.000841	CcSEcCtD
Vincristine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000135	0.000827	CcSEcCtD
Vincristine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000133	0.000816	CcSEcCtD
Vincristine—Oedema—Prednisone—multiple sclerosis	0.000133	0.000816	CcSEcCtD
Vincristine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000133	0.000816	CcSEcCtD
Vincristine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000133	0.000814	CcSEcCtD
Vincristine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000133	0.000814	CcSEcCtD
Vincristine—Decreased appetite—Betamethasone—multiple sclerosis	0.000133	0.000814	CcSEcCtD
Vincristine—Nausea—Mitoxantrone—multiple sclerosis	0.000133	0.000813	CcSEcCtD
Vincristine—Infection—Prednisone—multiple sclerosis	0.000132	0.00081	CcSEcCtD
Vincristine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000132	0.000809	CcSEcCtD
Vincristine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000132	0.000809	CcSEcCtD
Vincristine—Back pain—Methotrexate—multiple sclerosis	0.000132	0.000808	CcSEcCtD
Vincristine—Fatigue—Dexamethasone—multiple sclerosis	0.000132	0.000808	CcSEcCtD
Vincristine—Fatigue—Betamethasone—multiple sclerosis	0.000132	0.000808	CcSEcCtD
Vincristine—Pain—Dexamethasone—multiple sclerosis	0.000131	0.000801	CcSEcCtD
Vincristine—Pain—Betamethasone—multiple sclerosis	0.000131	0.000801	CcSEcCtD
Vincristine—Nervous system disorder—Prednisone—multiple sclerosis	0.00013	0.0008	CcSEcCtD
Vincristine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000129	0.000789	CcSEcCtD
Vincristine—Anorexia—Prednisone—multiple sclerosis	0.000127	0.000778	CcSEcCtD
Vincristine—Anaemia—Methotrexate—multiple sclerosis	0.000126	0.000772	CcSEcCtD
Vincristine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000125	0.000766	CcSEcCtD
Vincristine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000125	0.000766	CcSEcCtD
Vincristine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000124	0.000761	CcSEcCtD
Vincristine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000124	0.000759	CcSEcCtD
Vincristine—Vertigo—Methotrexate—multiple sclerosis	0.000122	0.00075	CcSEcCtD
Vincristine—Leukopenia—Methotrexate—multiple sclerosis	0.000122	0.000748	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000121	0.000743	CcSEcCtD
Vincristine—Dizziness—Prednisolone—multiple sclerosis	0.000121	0.000742	CcSEcCtD
Vincristine—Asthenia—Triamcinolone—multiple sclerosis	0.000121	0.000741	CcSEcCtD
Vincristine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000121	0.00074	CcSEcCtD
Vincristine—Body temperature increased—Betamethasone—multiple sclerosis	0.000121	0.00074	CcSEcCtD
Vincristine—Abdominal pain—Betamethasone—multiple sclerosis	0.000121	0.00074	CcSEcCtD
Vincristine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000121	0.00074	CcSEcCtD
Vincristine—Asthenia—Methylprednisolone—multiple sclerosis	0.000121	0.000739	CcSEcCtD
Vincristine—Insomnia—Prednisone—multiple sclerosis	0.00012	0.000738	CcSEcCtD
Vincristine—Paraesthesia—Prednisone—multiple sclerosis	0.000119	0.000732	CcSEcCtD
Vincristine—Convulsion—Methotrexate—multiple sclerosis	0.000118	0.000724	CcSEcCtD
Vincristine—Myalgia—Methotrexate—multiple sclerosis	0.000116	0.000711	CcSEcCtD
Vincristine—Decreased appetite—Prednisone—multiple sclerosis	0.000116	0.000709	CcSEcCtD
Vincristine—Rash—Prednisolone—multiple sclerosis	0.000115	0.000708	CcSEcCtD
Vincristine—Dermatitis—Prednisolone—multiple sclerosis	0.000115	0.000707	CcSEcCtD
Vincristine—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000115	0.000705	CcSEcCtD
Vincristine—ABCB1—brain—multiple sclerosis	0.000115	0.00156	CbGeAlD
Vincristine—Fatigue—Prednisone—multiple sclerosis	0.000115	0.000703	CcSEcCtD
Vincristine—Headache—Prednisolone—multiple sclerosis	0.000115	0.000703	CcSEcCtD
Vincristine—Constipation—Prednisone—multiple sclerosis	0.000114	0.000698	CcSEcCtD
Vincristine—Dizziness—Triamcinolone—multiple sclerosis	0.000111	0.000683	CcSEcCtD
Vincristine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000111	0.000682	CcSEcCtD
Vincristine—Dizziness—Methylprednisolone—multiple sclerosis	0.000111	0.000681	CcSEcCtD
Vincristine—Infection—Methotrexate—multiple sclerosis	0.00011	0.000677	CcSEcCtD
Vincristine—Asthenia—Betamethasone—multiple sclerosis	0.00011	0.000672	CcSEcCtD
Vincristine—Asthenia—Dexamethasone—multiple sclerosis	0.00011	0.000672	CcSEcCtD
Vincristine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000109	0.000669	CcSEcCtD
Vincristine—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000109	0.000667	CcSEcCtD
Vincristine—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000109	0.000667	CcSEcCtD
Vincristine—Nausea—Prednisolone—multiple sclerosis	0.000109	0.000667	CcSEcCtD
Vincristine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000107	0.000659	CcSEcCtD
Vincristine—Vomiting—Triamcinolone—multiple sclerosis	0.000107	0.000656	CcSEcCtD
Vincristine—Vomiting—Methylprednisolone—multiple sclerosis	0.000107	0.000655	CcSEcCtD
Vincristine—Rash—Triamcinolone—multiple sclerosis	0.000106	0.000651	CcSEcCtD
Vincristine—Dermatitis—Triamcinolone—multiple sclerosis	0.000106	0.00065	CcSEcCtD
Vincristine—Anorexia—Methotrexate—multiple sclerosis	0.000106	0.00065	CcSEcCtD
Vincristine—Rash—Methylprednisolone—multiple sclerosis	0.000106	0.000649	CcSEcCtD
Vincristine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000106	0.000649	CcSEcCtD
Vincristine—Headache—Triamcinolone—multiple sclerosis	0.000105	0.000647	CcSEcCtD
Vincristine—Headache—Methylprednisolone—multiple sclerosis	0.000105	0.000645	CcSEcCtD
Vincristine—Body temperature increased—Prednisone—multiple sclerosis	0.000105	0.000645	CcSEcCtD
Vincristine—Abdominal pain—Prednisone—multiple sclerosis	0.000105	0.000645	CcSEcCtD
Vincristine—Diarrhoea—Betamethasone—multiple sclerosis	0.000105	0.000641	CcSEcCtD
Vincristine—Diarrhoea—Dexamethasone—multiple sclerosis	0.000105	0.000641	CcSEcCtD
Vincristine—Hypotension—Methotrexate—multiple sclerosis	0.000104	0.000637	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000101	0.000621	CcSEcCtD
Vincristine—Dizziness—Dexamethasone—multiple sclerosis	0.000101	0.000619	CcSEcCtD
Vincristine—Dizziness—Betamethasone—multiple sclerosis	0.000101	0.000619	CcSEcCtD
Vincristine—Insomnia—Methotrexate—multiple sclerosis	0.000101	0.000617	CcSEcCtD
Vincristine—Nausea—Triamcinolone—multiple sclerosis	0.0001	0.000613	CcSEcCtD
Vincristine—Paraesthesia—Methotrexate—multiple sclerosis	9.98e-05	0.000612	CcSEcCtD
Vincristine—Nausea—Methylprednisolone—multiple sclerosis	9.98e-05	0.000612	CcSEcCtD
Vincristine—Hypersensitivity—Prednisone—multiple sclerosis	9.8e-05	0.000601	CcSEcCtD
Vincristine—Vomiting—Dexamethasone—multiple sclerosis	9.71e-05	0.000596	CcSEcCtD
Vincristine—Vomiting—Betamethasone—multiple sclerosis	9.71e-05	0.000596	CcSEcCtD
Vincristine—Decreased appetite—Methotrexate—multiple sclerosis	9.67e-05	0.000593	CcSEcCtD
Vincristine—Rash—Betamethasone—multiple sclerosis	9.63e-05	0.000591	CcSEcCtD
Vincristine—Rash—Dexamethasone—multiple sclerosis	9.63e-05	0.000591	CcSEcCtD
Vincristine—Dermatitis—Betamethasone—multiple sclerosis	9.62e-05	0.00059	CcSEcCtD
Vincristine—Dermatitis—Dexamethasone—multiple sclerosis	9.62e-05	0.00059	CcSEcCtD
Vincristine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	9.6e-05	0.000589	CcSEcCtD
Vincristine—Fatigue—Methotrexate—multiple sclerosis	9.59e-05	0.000588	CcSEcCtD
Vincristine—Headache—Dexamethasone—multiple sclerosis	9.57e-05	0.000587	CcSEcCtD
Vincristine—Headache—Betamethasone—multiple sclerosis	9.57e-05	0.000587	CcSEcCtD
Vincristine—Asthenia—Prednisone—multiple sclerosis	9.55e-05	0.000585	CcSEcCtD
Vincristine—Pain—Methotrexate—multiple sclerosis	9.51e-05	0.000583	CcSEcCtD
Vincristine—Diarrhoea—Prednisone—multiple sclerosis	9.1e-05	0.000558	CcSEcCtD
Vincristine—Gastrointestinal pain—Methotrexate—multiple sclerosis	9.09e-05	0.000557	CcSEcCtD
Vincristine—Nausea—Dexamethasone—multiple sclerosis	9.07e-05	0.000556	CcSEcCtD
Vincristine—Nausea—Betamethasone—multiple sclerosis	9.07e-05	0.000556	CcSEcCtD
Vincristine—Dizziness—Prednisone—multiple sclerosis	8.8e-05	0.000539	CcSEcCtD
Vincristine—Body temperature increased—Methotrexate—multiple sclerosis	8.79e-05	0.000539	CcSEcCtD
Vincristine—Abdominal pain—Methotrexate—multiple sclerosis	8.79e-05	0.000539	CcSEcCtD
Vincristine—Vomiting—Prednisone—multiple sclerosis	8.46e-05	0.000519	CcSEcCtD
Vincristine—Rash—Prednisone—multiple sclerosis	8.39e-05	0.000514	CcSEcCtD
Vincristine—Dermatitis—Prednisone—multiple sclerosis	8.38e-05	0.000514	CcSEcCtD
Vincristine—Headache—Prednisone—multiple sclerosis	8.33e-05	0.000511	CcSEcCtD
Vincristine—Hypersensitivity—Methotrexate—multiple sclerosis	8.19e-05	0.000502	CcSEcCtD
Vincristine—Asthenia—Methotrexate—multiple sclerosis	7.98e-05	0.000489	CcSEcCtD
Vincristine—Nausea—Prednisone—multiple sclerosis	7.9e-05	0.000485	CcSEcCtD
Vincristine—Diarrhoea—Methotrexate—multiple sclerosis	7.61e-05	0.000466	CcSEcCtD
Vincristine—Dizziness—Methotrexate—multiple sclerosis	7.35e-05	0.000451	CcSEcCtD
Vincristine—Vomiting—Methotrexate—multiple sclerosis	7.07e-05	0.000433	CcSEcCtD
Vincristine—Rash—Methotrexate—multiple sclerosis	7.01e-05	0.00043	CcSEcCtD
Vincristine—Dermatitis—Methotrexate—multiple sclerosis	7e-05	0.000429	CcSEcCtD
Vincristine—Headache—Methotrexate—multiple sclerosis	6.97e-05	0.000427	CcSEcCtD
Vincristine—Nausea—Methotrexate—multiple sclerosis	6.6e-05	0.000405	CcSEcCtD
Vincristine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	6.41e-05	0.00116	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—SRM—multiple sclerosis	6.36e-05	0.00115	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—RPL5—multiple sclerosis	6.34e-05	0.00114	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.18e-05	0.00111	CbGpPWpGaD
Vincristine—TUBB2B—Metabolism of proteins—BCHE—multiple sclerosis	6.18e-05	0.00111	CbGpPWpGaD
Vincristine—TUBB6—Metabolism of proteins—BCHE—multiple sclerosis	6.18e-05	0.00111	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.16e-05	0.00111	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	6.13e-05	0.0011	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.11e-05	0.0011	CbGpPWpGaD
Vincristine—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	6.01e-05	0.00108	CbGpPWpGaD
Vincristine—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	6.01e-05	0.00108	CbGpPWpGaD
Vincristine—TUBB3—Metabolism of proteins—BCHE—multiple sclerosis	5.97e-05	0.00108	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—IL2RA—multiple sclerosis	5.97e-05	0.00108	CbGpPWpGaD
Vincristine—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	5.93e-05	0.00107	CbGpPWpGaD
Vincristine—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	5.93e-05	0.00107	CbGpPWpGaD
Vincristine—SLC22A3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.93e-05	0.00107	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—CD86—multiple sclerosis	5.9e-05	0.00106	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	5.79e-05	0.00104	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—IL10—multiple sclerosis	5.79e-05	0.00104	CbGpPWpGaD
Vincristine—TUBB2A—Metabolism of proteins—BCHE—multiple sclerosis	5.78e-05	0.00104	CbGpPWpGaD
Vincristine—TUBB1—Metabolism of proteins—BCHE—multiple sclerosis	5.65e-05	0.00102	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—IL4—multiple sclerosis	5.63e-05	0.00102	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	5.51e-05	0.000993	CbGpPWpGaD
Vincristine—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.48e-05	0.000987	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.45e-05	0.000982	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.37e-05	0.000969	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	5.29e-05	0.000954	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—FAS—multiple sclerosis	5.19e-05	0.000935	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	5.19e-05	0.000935	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	5.16e-05	0.00093	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	5.1e-05	0.00092	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CCL3—multiple sclerosis	5.08e-05	0.000916	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—BCHE—multiple sclerosis	5.07e-05	0.000914	CbGpPWpGaD
Vincristine—ABCC10—Transmembrane transport of small molecules—ALB—multiple sclerosis	5.06e-05	0.000913	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—SRM—multiple sclerosis	4.98e-05	0.000898	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PTGER4—multiple sclerosis	4.89e-05	0.000881	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.89e-05	0.000881	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—CYP27B1—multiple sclerosis	4.87e-05	0.000878	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—CYP24A1—multiple sclerosis	4.87e-05	0.000878	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—VDR—multiple sclerosis	4.87e-05	0.000877	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.83e-05	0.00087	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PGR—multiple sclerosis	4.82e-05	0.000868	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CXCR3—multiple sclerosis	4.72e-05	0.000851	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CD28—multiple sclerosis	4.68e-05	0.000843	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—CYP27B1—multiple sclerosis	4.67e-05	0.000842	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—CYP24A1—multiple sclerosis	4.67e-05	0.000842	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	4.66e-05	0.00084	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—BCHE—multiple sclerosis	4.64e-05	0.000836	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CCR2—multiple sclerosis	4.59e-05	0.000828	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.57e-05	0.000823	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—CYP24A1—multiple sclerosis	4.48e-05	0.000807	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—CYP27B1—multiple sclerosis	4.48e-05	0.000807	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—GPC5—multiple sclerosis	4.46e-05	0.000803	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—SRM—multiple sclerosis	4.38e-05	0.00079	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.38e-05	0.000789	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—SRM—multiple sclerosis	4.34e-05	0.000783	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.32e-05	0.000778	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—ALB—multiple sclerosis	4.31e-05	0.000777	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—CD80—multiple sclerosis	4.31e-05	0.000776	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—GPC5—multiple sclerosis	4.27e-05	0.00077	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.27e-05	0.000769	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.25e-05	0.000766	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CNR1—multiple sclerosis	4.24e-05	0.000764	CbGpPWpGaD
Vincristine—SLC22A3—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.2e-05	0.000757	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—GPC5—multiple sclerosis	4.1e-05	0.000738	CbGpPWpGaD
Vincristine—CYP3A7—Biological oxidations—POMC—multiple sclerosis	4.03e-05	0.000726	CbGpPWpGaD
Vincristine—NR0B1—Generic Transcription Pathway—MYC—multiple sclerosis	4.02e-05	0.000724	CbGpPWpGaD
Vincristine—ABCC3—NRF2 pathway—TGFB1—multiple sclerosis	3.87e-05	0.000698	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.83e-05	0.000691	CbGpPWpGaD
Vincristine—ABCC1—Disease—GPC5—multiple sclerosis	3.83e-05	0.000691	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CXCL10—multiple sclerosis	3.82e-05	0.000688	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.76e-05	0.000677	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	3.73e-05	0.000672	CbGpPWpGaD
Vincristine—TUBA4A—Metabolism of proteins—POMC—multiple sclerosis	3.72e-05	0.000671	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—RRM1—multiple sclerosis	3.69e-05	0.000666	CbGpPWpGaD
Vincristine—TUBA4A—Metabolism of proteins—CCL2—multiple sclerosis	3.64e-05	0.000656	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—RRM1—multiple sclerosis	3.54e-05	0.000638	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CYP27B1—multiple sclerosis	3.51e-05	0.000632	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CYP24A1—multiple sclerosis	3.51e-05	0.000632	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—IL2—multiple sclerosis	3.5e-05	0.00063	CbGpPWpGaD
Vincristine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	3.47e-05	0.000625	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.43e-05	0.000618	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	3.4e-05	0.000614	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—RRM1—multiple sclerosis	3.39e-05	0.000612	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CD86—multiple sclerosis	3.34e-05	0.000602	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CCL5—multiple sclerosis	3.29e-05	0.000592	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GPC5—multiple sclerosis	3.21e-05	0.000578	CbGpPWpGaD
Vincristine—TUBB2B—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.2e-05	0.000577	CbGpPWpGaD
Vincristine—TUBB6—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.2e-05	0.000577	CbGpPWpGaD
Vincristine—TUBB6—Metabolism of proteins—POMC—multiple sclerosis	3.19e-05	0.000575	CbGpPWpGaD
Vincristine—TUBB2B—Metabolism of proteins—POMC—multiple sclerosis	3.19e-05	0.000575	CbGpPWpGaD
Vincristine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.14e-05	0.000566	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—SRM—multiple sclerosis	3.14e-05	0.000566	CbGpPWpGaD
Vincristine—TUBB6—Metabolism of proteins—CCL2—multiple sclerosis	3.12e-05	0.000563	CbGpPWpGaD
Vincristine—TUBB2B—Metabolism of proteins—CCL2—multiple sclerosis	3.12e-05	0.000563	CbGpPWpGaD
Vincristine—TUBB3—Transmembrane transport of small molecules—ALB—multiple sclerosis	3.09e-05	0.000558	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CYP27B1—multiple sclerosis	3.09e-05	0.000557	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CYP24A1—multiple sclerosis	3.09e-05	0.000557	CbGpPWpGaD
Vincristine—TUBB3—Metabolism of proteins—POMC—multiple sclerosis	3.08e-05	0.000556	CbGpPWpGaD
Vincristine—ABCC2—NRF2 pathway—TGFB1—multiple sclerosis	3.07e-05	0.000553	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	3.06e-05	0.000552	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	3.06e-05	0.000552	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—SPP1—multiple sclerosis	3.04e-05	0.000548	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	3.04e-05	0.000547	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—IL2—multiple sclerosis	3.03e-05	0.000545	CbGpPWpGaD
Vincristine—TUBB3—Metabolism of proteins—CCL2—multiple sclerosis	3.02e-05	0.000544	CbGpPWpGaD
Vincristine—TUBB2A—Transmembrane transport of small molecules—ALB—multiple sclerosis	3e-05	0.00054	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	2.99e-05	0.000539	CbGpPWpGaD
Vincristine—TUBB2A—Metabolism of proteins—POMC—multiple sclerosis	2.99e-05	0.000538	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CCR5—multiple sclerosis	2.96e-05	0.000534	CbGpPWpGaD
Vincristine—TUBB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.93e-05	0.000528	CbGpPWpGaD
Vincristine—TUBB2A—Metabolism of proteins—CCL2—multiple sclerosis	2.92e-05	0.000527	CbGpPWpGaD
Vincristine—TUBB1—Metabolism of proteins—POMC—multiple sclerosis	2.92e-05	0.000526	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IL2RA—multiple sclerosis	2.92e-05	0.000526	CbGpPWpGaD
Vincristine—CYP3A5—Biological oxidations—POMC—multiple sclerosis	2.91e-05	0.000525	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.91e-05	0.000524	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—MYC—multiple sclerosis	2.89e-05	0.00052	CbGpPWpGaD
Vincristine—TUBB1—Metabolism of proteins—CCL2—multiple sclerosis	2.86e-05	0.000515	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GPC5—multiple sclerosis	2.82e-05	0.000509	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	2.82e-05	0.000509	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GPC5—multiple sclerosis	2.8e-05	0.000505	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.75e-05	0.000495	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—TGFB1—multiple sclerosis	2.73e-05	0.000492	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—APOE—multiple sclerosis	2.69e-05	0.000485	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—MAPK1—multiple sclerosis	2.68e-05	0.000482	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—RRM1—multiple sclerosis	2.66e-05	0.000479	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.63e-05	0.000475	CbGpPWpGaD
Vincristine—TUBB4A—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.63e-05	0.000474	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—POMC—multiple sclerosis	2.62e-05	0.000473	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—MYC—multiple sclerosis	2.58e-05	0.000465	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—CCL2—multiple sclerosis	2.57e-05	0.000462	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.56e-05	0.000462	CbGpPWpGaD
Vincristine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.55e-05	0.000459	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—MAPK1—multiple sclerosis	2.52e-05	0.000455	CbGpPWpGaD
Vincristine—ABCC1—Disease—RPL5—multiple sclerosis	2.49e-05	0.000449	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—MYC—multiple sclerosis	2.45e-05	0.000442	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CD80—multiple sclerosis	2.43e-05	0.000439	CbGpPWpGaD
Vincristine—TUBB4B—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.41e-05	0.000434	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	2.4e-05	0.000433	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—POMC—multiple sclerosis	2.4e-05	0.000432	CbGpPWpGaD
Vincristine—ABCC1—Disease—SLC11A1—multiple sclerosis	2.39e-05	0.00043	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—SRM—multiple sclerosis	2.37e-05	0.000427	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	2.36e-05	0.000425	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.36e-05	0.000425	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—CCL2—multiple sclerosis	2.35e-05	0.000423	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—RRM1—multiple sclerosis	2.34e-05	0.000422	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—RRM1—multiple sclerosis	2.32e-05	0.000418	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—POMC—multiple sclerosis	2.31e-05	0.000417	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.3e-05	0.000414	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CCL2—multiple sclerosis	2.26e-05	0.000408	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.26e-05	0.000408	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	2.21e-05	0.000399	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	2.21e-05	0.000399	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.2e-05	0.000397	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—MYC—multiple sclerosis	2.19e-05	0.000395	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.15e-05	0.000388	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—MAPK1—multiple sclerosis	2.15e-05	0.000387	CbGpPWpGaD
Vincristine—SLC22A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.13e-05	0.000385	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—BCHE—multiple sclerosis	2.12e-05	0.000382	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.06e-05	0.000372	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.06e-05	0.000372	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TYK2—multiple sclerosis	2.06e-05	0.00037	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—BCHE—multiple sclerosis	2.03e-05	0.000366	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—MYC—multiple sclerosis	2.03e-05	0.000366	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.03e-05	0.000366	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GPC5—multiple sclerosis	2.02e-05	0.000365	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	1.99e-05	0.000359	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.96e-05	0.000353	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—BCHE—multiple sclerosis	1.95e-05	0.000351	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—MYC—multiple sclerosis	1.93e-05	0.000349	CbGpPWpGaD
Vincristine—ABCC1—Disease—CD28—multiple sclerosis	1.91e-05	0.000344	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—MYC—multiple sclerosis	1.86e-05	0.000335	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—MAPK1—multiple sclerosis	1.82e-05	0.000328	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MYC—multiple sclerosis	1.82e-05	0.000328	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MAPK1—multiple sclerosis	1.78e-05	0.000321	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.77e-05	0.000319	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IL2—multiple sclerosis	1.71e-05	0.000308	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.68e-05	0.000302	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.67e-05	0.000301	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.67e-05	0.000301	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MYC—multiple sclerosis	1.66e-05	0.0003	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MAPK1—multiple sclerosis	1.63e-05	0.000293	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MMP9—multiple sclerosis	1.62e-05	0.000292	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.62e-05	0.000291	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.55e-05	0.00028	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.54e-05	0.000277	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—BCHE—multiple sclerosis	1.53e-05	0.000275	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GPC5—multiple sclerosis	1.53e-05	0.000275	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—SRM—multiple sclerosis	1.46e-05	0.000263	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—STAT3—multiple sclerosis	1.44e-05	0.000259	CbGpPWpGaD
Vincristine—ABCC1—Disease—CD86—multiple sclerosis	1.36e-05	0.000245	CbGpPWpGaD
Vincristine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.35e-05	0.000244	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.35e-05	0.000244	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—BCHE—multiple sclerosis	1.34e-05	0.000242	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MYC—multiple sclerosis	1.34e-05	0.000241	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TGFB1—multiple sclerosis	1.33e-05	0.00024	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.33e-05	0.00024	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MAPK1—multiple sclerosis	1.31e-05	0.000236	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—APOE—multiple sclerosis	1.28e-05	0.00023	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—RRM1—multiple sclerosis	1.27e-05	0.000228	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—APOE—multiple sclerosis	1.22e-05	0.00022	CbGpPWpGaD
Vincristine—ABCC1—Disease—CCR5—multiple sclerosis	1.21e-05	0.000217	CbGpPWpGaD
Vincristine—ABCC1—Disease—HLA-A—multiple sclerosis	1.18e-05	0.000212	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—APOE—multiple sclerosis	1.17e-05	0.000211	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.17e-05	0.00021	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.16e-05	0.00021	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.14e-05	0.000206	CbGpPWpGaD
Vincristine—ABCC1—Disease—APOE—multiple sclerosis	1.1e-05	0.000198	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—POMC—multiple sclerosis	1.1e-05	0.000198	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.09e-05	0.000196	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—POMC—multiple sclerosis	1.05e-05	0.000189	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.03e-05	0.000185	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.03e-05	0.000185	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—POMC—multiple sclerosis	1.01e-05	0.000182	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IL6—multiple sclerosis	1.01e-05	0.000181	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ALB—multiple sclerosis	9.99e-06	0.00018	CbGpPWpGaD
Vincristine—ABCC1—Disease—CD80—multiple sclerosis	9.92e-06	0.000179	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—BCHE—multiple sclerosis	9.63e-06	0.000174	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ALB—multiple sclerosis	9.58e-06	0.000173	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GPC5—multiple sclerosis	9.41e-06	0.00017	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—APOE—multiple sclerosis	9.19e-06	0.000166	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ALB—multiple sclerosis	9.19e-06	0.000166	CbGpPWpGaD
Vincristine—ABCC1—Disease—TYK2—multiple sclerosis	8.37e-06	0.000151	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—APOE—multiple sclerosis	8.09e-06	0.000146	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—APOE—multiple sclerosis	8.01e-06	0.000144	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—POMC—multiple sclerosis	7.89e-06	0.000142	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—RRM1—multiple sclerosis	7.8e-06	0.00014	CbGpPWpGaD
Vincristine—ABCC1—Disease—CD4—multiple sclerosis	7.57e-06	0.000137	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	7.31e-06	0.000132	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—BCHE—multiple sclerosis	7.27e-06	0.000131	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ALB—multiple sclerosis	7.2e-06	0.00013	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—POMC—multiple sclerosis	6.95e-06	0.000125	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—POMC—multiple sclerosis	6.89e-06	0.000124	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ALB—multiple sclerosis	6.33e-06	0.000114	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ALB—multiple sclerosis	6.28e-06	0.000113	CbGpPWpGaD
Vincristine—ABCC1—Disease—STAT3—multiple sclerosis	5.86e-06	0.000106	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—APOE—multiple sclerosis	5.79e-06	0.000104	CbGpPWpGaD
Vincristine—ABCC1—Disease—MYC—multiple sclerosis	5.45e-06	9.82e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—TGFB1—multiple sclerosis	5.44e-06	9.8e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MAPK1—multiple sclerosis	5.33e-06	9.61e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—POMC—multiple sclerosis	4.98e-06	8.97e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ALB—multiple sclerosis	4.54e-06	8.18e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—BCHE—multiple sclerosis	4.48e-06	8.07e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—APOE—multiple sclerosis	4.37e-06	7.88e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—IL6—multiple sclerosis	4.1e-06	7.38e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—POMC—multiple sclerosis	3.76e-06	6.77e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ALB—multiple sclerosis	3.42e-06	6.17e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—APOE—multiple sclerosis	2.69e-06	4.85e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—POMC—multiple sclerosis	2.31e-06	4.17e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ALB—multiple sclerosis	2.11e-06	3.8e-05	CbGpPWpGaD
